Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SNY

Sanofi ADR

Sep 09 • 04:00PM ET

58.51

Dollar change +0.78
Percentage change 1.35	%

Healthcare • Drug Manufacturers - General • France • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: FVD GCOW PPH PID PVAL AVDE PINK FENI QQQJ APIE

Scroll to Statements

Index	-	P/E	32.26	EPS (ttm)	1.81	Insider Own	0.00%	Shs Outstand	2.51B	Perf Week	4.00%
Market Cap	146.66B	Forward P/E	12.12	EPS next Y	4.83	Insider Trans	-	Shs Float	2.51B	Perf Month	12.28%
Income	4.56B	PEG	3.58	EPS next Q	1.38	Inst Own	10.88%	Short Float	0.45%	Perf Quarter	19.46%
Sales	47.68B	P/S	3.08	EPS this Y	-3.58%	Inst Trans	-1.62%	Short Ratio	4.98	Perf Half Y	21.26%
Book/sh	31.14	P/B	1.88	EPS next Y	14.02%	ROA	3.31%	Short Interest	11.37M	Perf Year	10.33%
Cash/sh	2.91	P/C	20.14	EPS next 5Y	9.00%	ROE	5.80%	52W Range	42.63 - 58.97	Perf YTD	17.66%
Dividend Est.	2.11 (3.61%)	P/FCF	24.90	EPS past 5Y	2.68%	ROI	4.89%	52W High	-0.78%	Beta	0.56
Dividend TTM	2.04 (3.48%)	Quick Ratio	0.65	Sales past 5Y	2.80%	Gross Margin	61.47%	52W Low	37.25%	ATR (14)	0.83
Dividend Ex-Date	May 09, 2024	Current Ratio	1.00	EPS Y/Y TTM	-49.09%	Oper. Margin	21.26%	RSI (14)	74.86	Volatility	1.36% 1.06%
Employees	87994	Debt/Eq	0.33	Sales Y/Y TTM	5.18%	Profit Margin	9.56%	Recom	1.61	Target Price	60.86
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	-	Payout	63.38%	Rel Volume	0.40	Prev Close	57.73
Sales Surprise	3.35%	EPS Surprise	3.11%	Sales Q/Q	-13.36%	Earnings	Jul 25 BMO	Avg Volume	2.28M	Price	58.51
SMA20	5.52%	SMA50	11.13%	SMA200	18.36%	Trades		Volume	907,902	Change	1.35%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Reiterated	Argus	Buy	$55 → $60
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$55
Jan-16-24	Resumed	UBS	Buy
Dec-05-23	Downgrade	JP Morgan	Overweight → Neutral
Oct-30-23	Downgrade	Stifel	Buy → Hold
Sep-06-23	Upgrade	Berenberg	Hold → Buy
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-28-23	Downgrade	Deutsche Bank	Hold → Sell
Mar-27-23	Upgrade	Barclays	Equal Weight → Overweight
Dec-13-22	Resumed	Morgan Stanley	Overweight
Aug-12-22	Upgrade	Deutsche Bank	Sell → Hold
Aug-09-22	Downgrade	UBS	Buy → Neutral
May-23-22	Initiated	SVB Leerink	Outperform
Sep-27-21	Upgrade	SVB Leerink	Mkt Perform → Outperform
Jan-15-21	Initiated	Deutsche Bank	Sell
Sep-29-20	Initiated	Berenberg	Hold
Mar-17-20	Upgrade	Barclays	Underweight → Equal Weight
Mar-11-20	Upgrade	Goldman	Neutral → Buy
Feb-11-20	Initiated	SVB Leerink	Mkt Perform
Jan-06-20	Upgrade	JP Morgan	Neutral → Overweight

Show Previous Ratings

Today 04:32AM	Vir Biotechnology closes Sanofi licence deal for T-cell engagers (Pharmaceutical Technology)
Sep-06-24 10:33AM	Men taking valproate and their partners warned to use contraception by MHRA (Pharmaceutical Technology)
Sep-05-24 11:44AM	Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? (Investor's Business Daily)
Sep-03-24 07:31PM	Analyst Report: Sanofi (Morningstar Research)
06:16PM	Why Sanofi Stock Was Robustly Healthy Today (Motley Fool)
07:56AM	Loading…
07:56AM	Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials (Benzinga)
07:01AM	Sanofi finds a silver lining in mixed MS drug results (BioPharma Dive)
Sep-02-24 06:53AM	Sanofi reports data from Phase III multiple sclerosis trials of tolebrutinib (Clinical Trials Arena)
01:34AM	Sanofi Multiple Sclerosis Drug Delays Disability Progression in Trial (The Wall Street Journal)
01:34AM	Sanofi MS Drug Meets Goal of Reducing Disability in Late-Stage Trial (The Wall Street Journal)
01:00AM	Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis (GlobeNewswire)
Aug-31-24 02:09PM	Exscientia Plc (EXAI): A Penny Stock That Will Make You a Millionaire (Insider Monkey)
Aug-28-24 12:11PM	Sanofi (SNY): A Cheap Pharmaceutical Stock to Buy According to Short Sellers (Insider Monkey)
Aug-23-24 10:15PM	Top 25 Eco-Friendly Companies in 2024 (Insider Monkey)
Aug-22-24 10:58AM	PAI Said to Rope in Sovereign Funds for Sanofi Consumer Unit Bid (Bloomberg)
06:00AM	Loading…
Aug-15-24 06:00AM	3 Biotech Stocks to Buy on the Dip: August 2024 (InvestorPlace)
Aug-14-24 04:11PM	AnaptysBio Surges After Sanofi Takes A Stake In $100 Million Offering (Investor's Business Daily)
10:05AM	AnaptysBio Hits Five-Year High After Sanofi Takes A Stake In $100 Million Offering (Investor's Business Daily)
Aug-09-24 03:11PM	Sanofi: Information concerning the total number of voting rights and shares - July 2024 (GlobeNewswire)
07:33AM	Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now? (Insider Monkey)
Aug-08-24 12:23PM	Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant (Benzinga)
11:13AM	Sanofis Sarclisa wins in transplant-eligible multiple myeloma trial (Clinical Trials Arena)
01:00AM	Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant (GlobeNewswire)
Aug-06-24 09:00AM	Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities (GlobeNewswire)
05:52AM	Vir Bio trims staff and pipeline to focus on Sanofi-licensed programmes (Clinical Trials Arena)
Aug-03-24 05:29AM	Where Will Novavax Be in 5 Years? (Motley Fool)
Aug-02-24 11:53AM	Vir Bio trims staff and pipeline to focus on Sanofi-licensed programmes (Pharmaceutical Technology)
06:32AM	Sanofi invests $1.4bn in insulin production in Germany (Pharmaceutical Technology)
03:59AM	Q2 2024 Regeneron Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-01-24 01:23PM	Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs (Benzinga)
09:54AM	Loading…
Jul-31-24 09:54AM	Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma (CNBC TV)
Jul-30-24 04:05PM	Novavax Sinks 26%. Vaccine Demand Triggers Downgrade. (Barrons.com)
Jul-26-24 11:17AM	Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza (PR Newswire)
Jul-25-24 04:07PM	AstraZeneca Says It Has A 'Powerful' And Differentiated Approach To Obesity Treatment (Investor's Business Daily)
02:13PM	Analyst Report: Sanofi (Morningstar Research)
01:30PM	Sanofi (SNY) Q2 2024 Earnings Call Transcript (Motley Fool)
01:20PM	Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season (PR Newswire)
11:09AM	AstraZeneca Makes A Bearish Move Despite Quarterly Beat As FDA Panel Mulls Cancer Drug (Investor's Business Daily)
10:57AM	Press Release: Online availability of Sanofi's half-year financial report for 2024 (GlobeNewswire)
10:40AM	Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised (Zacks)
09:20AM	AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook (Investor's Business Daily)
08:20AM	Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand (Benzinga)
08:17AM	Sanofis immunology bet starts to pay off (BioPharma Dive)
05:57AM	Sanofi: Q2 Earnings Snapshot (Associated Press Finance)
02:18AM	Sanofi lifts FY guidance after strong Q2 results (Investing.com)
01:37AM	Sanofi lifts 2024 profit forecast on strength in Dupixent, new products (Reuters)
01:30AM	Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded (GlobeNewswire)
Jul-23-24 03:04PM	Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants (Benzinga)
Jul-22-24 10:17PM	Analysis-Drug giants eye China for deals despite growing Sino-US tensions (Reuters)
04:05PM	Sanofi: Information concerning the total number of voting rights and shares June 2024 (GlobeNewswire)
Jul-18-24 04:32AM	Sanofis ALTUVIIIO shows promise in paediatric haemophilia A treatment trial (Clinical Trials Arena)
Jul-17-24 05:27PM	Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A (GlobeNewswire)
08:00AM	Stable Blue-Chip Stocks to Buy Before Earnings Season (InvestorPlace)
07:50AM	Sanofis Consumer Arm Said to Draw Bids From Advent, PAI, CD&R (Bloomberg)
Jul-15-24 10:45AM	Ovid Therapeutics Inc. (OVID): One of the Best Penny Stocks to Buy Under $1 According to Hedge Funds? (Insider Monkey)
09:35AM	10 Best Penny Stocks to Buy Under $1 (Insider Monkey)
Jul-12-24 10:41AM	Banks Plan 6 Billion Debt Financing for Sanofi Consumer Sale (Bloomberg)
01:16AM	Sanofi partners with OpenAI to become the world's first AI-driven pharma giant (DigiTimes)
Jul-10-24 05:02PM	FTC plans to sue top 3 PBMs over insulin prices: WSJ (Yahoo Finance Video)
04:45PM	FTC to Sue Drug Managers Over Insulin Prices (The Wall Street Journal)
04:10PM	Sanofi ships U.S. influenza vaccines for the 2024/25 season (PR Newswire)
Jul-09-24 02:02PM	FTC Chair Khan slams PBMs for higher drug prices in an interim report on the industry (Yahoo Finance)
01:30PM	Why Kymera Therapeutics Stock Is Soaring Today (Motley Fool)
12:36PM	3 Stocks to Sell Immediately Based on the French Election Results (InvestorPlace)
12:22PM	Kymera Therapeutics soars as Sanofi expands phase 2 trials (Investing.com)
10:44AM	Kymera Therapeutics Soars as Sanofi Expands Studies of Its Skin Diseases Drug (Investopedia)
Jul-05-24 08:33AM	Dupixent addresses current gap in COPD biologics landscape (Pharmaceutical Technology)
Jul-04-24 12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
06:51AM	French State Investment Firm Eyes Stake in Sanofi Consumer Unit (Bloomberg)
04:13AM	Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit (Bloomberg)
Jul-03-24 10:00AM	7 Safe Haven Stocks to Buy Before the Next Market Correction (InvestorPlace)
08:55AM	Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data (Benzinga)
06:55AM	Novavax's Second Act: How a Fallen COVID Star Could Rise from the Ashes (InvestorPlace)
06:33AM	EMA approves Sanofis Dupixent for COPD treatment in adults (Pharmaceutical Technology)
01:00AM	Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD (GlobeNewswire)
01:00AM	Dupixent (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD (GlobeNewswire)
Jul-02-24 06:58PM	10 Best Undervalued Stocks To Buy Now (Insider Monkey)
Jul-01-24 11:00PM	Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. (InvestorPlace)
11:13AM	Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant (Benzinga)
11:13AM	Google DeepMind CEO: 'This Is the Next $100 Billion AI Business' (InvestorPlace)
10:24AM	Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons (Bloomberg)
07:38AM	Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX) (Insider Monkey)
04:32AM	Sanofi reports findings from Phase II relapsing MS treatment trial (Clinical Trials Arena)
01:39AM	Sanofi eyes German insulin investment of up to $1.6 billion, source says (Reuters)
Jun-29-24 08:55AM	Where Will Novavax Be in 1 Year? (Motley Fool)
08:35AM	10 Stocks to Buy and Sell Before the Third Quarter 2024 According to Jim Cramer (Insider Monkey)
Jun-28-24 07:49AM	PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar (BioPharma Dive)
Jun-27-24 03:13PM	GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1? (Insider Monkey)
06:53AM	Formation Bio secures $372m funds for AI-driven drug platform (Pharmaceutical Technology)
04:52AM	Sanofi reports positive data from Phase III EoE treatment trial (Clinical Trials Arena)
02:00AM	Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi (GlobeNewswire)
Jun-26-24 10:12PM	10 Best Healthcare Stocks to Buy Under $50 (Insider Monkey)
05:30PM	Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM (GlobeNewswire)
05:30PM	Dupixent (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine (GlobeNewswire)
05:42AM	Sanofi reports data from Phase II demyelinating polyneuropathy trial (Clinical Trials Arena)
04:15AM	Sanofi Seeks Initial Offers for Its $20 Billion Consumer Arm (Bloomberg)
03:12AM	Pharma M&A: The top high value deals in 2023 (Pharmaceutical Technology)
Jun-25-24 01:32PM	Press Release: Availability of the Q2 2024 Aide-m moire (GlobeNewswire)
Jun-21-24 03:52AM	Sanofi and Biovac partner to produce polio vaccines in Africa (Pharmaceutical Technology)
03:30AM	Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi's Executive Committee (GlobeNewswire)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNY

Sanofi ADR

Upgrade your FINVIZ experience